639 related articles for article (PubMed ID: 29737435)
1. Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer.
Khantasup K; Saiviroonporn P; Jarussophon S; Chantima W; Dharakul T
MAGMA; 2018 Oct; 31(5):633-644. PubMed ID: 29737435
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium-Loaded Solid Lipid Nanoparticles as a Tumor-Absorbable Contrast Agent for Early Diagnosis of Colorectal Tumors Using Magnetic Resonance Colonography.
Sun J; Zhang S; Jiang S; Bai W; Liu F; Yuan H; Ji J; Luo J; Han G; Chen L; Jin Y; Hu P; Yu L; Yang X
J Biomed Nanotechnol; 2016 Sep; 12(9):1709-23. PubMed ID: 29345451
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.
Unger EC; Shen D; Wu G; Stewart L; Matsunaga TO; Trouard TP
MAGMA; 1999 Aug; 8(3):154-62. PubMed ID: 10504042
[TBL] [Abstract][Full Text] [Related]
4. Improving Longitudinal Transversal Relaxation Of Gadolinium Chelate Using Silica Coating Magnetite Nanoparticles.
Xu K; Liu H; Zhang J; Tong H; Zhao Z; Zhang W
Int J Nanomedicine; 2019; 14():7879-7889. PubMed ID: 31576129
[TBL] [Abstract][Full Text] [Related]
5. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium-conjugated CB86: a novel TSPO-targeting MRI contrast agent for imaging of rheumatoid arthritis.
Hou Z; Wang Q; Guo Z; Wang T; Wu H; Ma C; Wang W; Su F; Zhang H; Su X
J Drug Target; 2020 Apr; 28(4):398-407. PubMed ID: 31530199
[TBL] [Abstract][Full Text] [Related]
7. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer.
Liu Y; Chen Z; Liu C; Yu D; Lu Z; Zhang N
Biomaterials; 2011 Aug; 32(22):5167-76. PubMed ID: 21521627
[TBL] [Abstract][Full Text] [Related]
9. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
10. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
Laus S; Ruloff R; Tóth E; Merbach AE
Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
[TBL] [Abstract][Full Text] [Related]
11. Porphyrin-containing Gadolinium Complex as a Tumor-targeting Magnetic Resonance Imaging (MRI) Contrast Agent.
Ouyang YH; Xu W; Zhou CK; Liu F; Li B; Yan GP; Yang L; Chen S; Jiang C
Curr Drug Deliv; 2018; 15(7):972-978. PubMed ID: 29629659
[TBL] [Abstract][Full Text] [Related]
12. Intercellular imaging by a polyarginine derived cell penetrating peptide labeled magnetic resonance contrast agent, diethylenetriamine pentaacetic acid gadolinium.
Guo YM; Liu M; Yang JL; Guo XJ; Wang SC; Duan XY; Wang P
Chin Med J (Engl); 2007 Jan; 120(1):50-5. PubMed ID: 17254488
[TBL] [Abstract][Full Text] [Related]
13. The synthesis of a D-glucosamine contrast agent, Gd-DTPA-DG, and its application in cancer molecular imaging with MRI.
Zhang W; Chen Y; Guo DJ; Huang ZW; Cai L; He L
Eur J Radiol; 2011 Sep; 79(3):369-74. PubMed ID: 21106316
[TBL] [Abstract][Full Text] [Related]
14. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent.
Sirlin CB; Vera DR; Corbeil JA; Caballero MB; Buxton RB; Mattrey RF
Acad Radiol; 2004 Dec; 11(12):1361-9. PubMed ID: 15596374
[TBL] [Abstract][Full Text] [Related]
16. Chitosan oligosaccharide based Gd-DTPA complex as a potential bimodal magnetic resonance imaging contrast agent.
Huang Y; Cao J; Zhang Q; Lu ZR; Hua MQ; Zhang XY; Gao H
Magn Reson Imaging; 2016 Jan; 34(1):1-7. PubMed ID: 26485295
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging of osteosarcoma using a bis(alendronate)-based bone-targeted contrast agent.
Ge P; Sheng F; Jin Y; Tong L; Du L; Zhang L; Tian N; Li G
Biomed Pharmacother; 2016 Dec; 84():423-429. PubMed ID: 27682736
[TBL] [Abstract][Full Text] [Related]
19. Biocompatible nanotemplate-engineered nanoparticles containing gadolinium: stability and relaxivity of a potential MRI contrast agent.
Zhu D; White RD; Hardy PA; Weerapreeyakul N; Sutthanut K; Jay M
J Nanosci Nanotechnol; 2006 Apr; 6(4):996-1003. PubMed ID: 16736756
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA.
Saito S; Obata A; Kashiwagi Y; Abe K; Murase K
Invest Radiol; 2013 Jul; 48(7):548-53. PubMed ID: 23442774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]